Cargando…
Kinase inhibition in autoimmunity and inflammation
Despite recent advances in the treatment of autoimmune and inflammatory diseases, unmet medical needs in some areas still exist. One of the main therapeutic approaches to alleviate dysregulated inflammation has been to target the activity of kinases that regulate production of inflammatory mediators...
Autores principales: | Zarrin, Ali A., Bao, Katherine, Lupardus, Patrick, Vucic, Domagoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569567/ https://www.ncbi.nlm.nih.gov/pubmed/33077936 http://dx.doi.org/10.1038/s41573-020-0082-8 |
Ejemplares similares
-
XIAP at the crossroads of cell death and inflammation
por: Vucic, Domagoj
Publicado: (2018) -
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions
por: Ferrao, Ryan, et al.
Publicado: (2017) -
The Role of Ubiquitination in TWEAK-Stimulated Signaling
por: Vucic, Domagoj
Publicado: (2013) -
Low Psychological Resilience in Older Individuals: An Association with Increased Inflammation, Oxidative Stress and the Presence of Chronic Medical Conditions
por: Majnarić, Ljiljana Trtica, et al.
Publicado: (2021) -
RIP1 kinase activity is critical for skin inflammation but not for viral propagation
por: Webster, Joshua D., et al.
Publicado: (2020)